Centre of Expertise for Health and Work Ability, Finnish Institute of Occupational Health, Helsinki, Finland.
BMJ Open. 2013 Aug 19;3(8):e003036. doi: 10.1136/bmjopen-2013-003036.
Earlier studies have suggested associations between metabolic factors and musculoskeletal pain or disorders. We studied the associations of obesity, lipids, other features of the metabolic syndrome and adipokines (adiponectin, leptin, resistin, visfatin) with upper extremity pain in a clinical population with incipient upper extremity soft tissue disorders (UESTDs).
A cross-sectional study.
Primary healthcare (occupational health service) with further examinations at a research institute.
Patients (N=163, 86% were women) seeking medical advice in the occupational health service due to incipient upper extremity symptoms with symptom duration of <1 month were referred for consultation to the Finnish Institute of Occupational Health from Spring 2006 to Fall 2008. We included all actively working subjects meeting diagnostic criteria based on physical examination. We excluded subjects meeting predetermined conditions.
Pain intensity was assessed with visual analogue scale and dichotomised at the highest tertile (cut-point 60).
Obesity (adjusted OR for high waist circumference 2.9, 95% CI 1.1 to 7.3), high-density lipoprotein cholesterol (OR 3.9, 95% CI 1.4 to 10.1 for low level) and triglycerides (OR 2.6, 95% CI 1.0 to 6.8 for high level) were associated with pain intensity. Of four adipokines studied, only visfatin was associated with upper extremity pain (adjusted OR 1.4, 95% CI 1.0 to 2.1 for 1SD increase in level).
Abdominal obesity and lipids may have an impact on pain intensity in UESTDs. They may intensify pain through proinflammatory pain-modifying molecular pathways or by causing soft tissue pathology and dysfunction of their supplying arteries. Of four adipokines studied only one (visfatin) was associated with pain intensity. In the future, further studies are required to better understand the relationship between metabolic factors and UESTDs.
早期研究表明代谢因素与肌肉骨骼疼痛或疾病之间存在关联。我们研究了肥胖、脂质、代谢综合征的其他特征以及脂肪因子(脂联素、瘦素、抵抗素、内脂素)与上肢软组织疾病(UESTD)初发患者上肢疼痛之间的关系。
横断面研究。
初级保健(职业健康服务),在研究机构进行进一步检查。
因上肢初期症状而在职业健康服务中寻求医疗建议的患者(163 例,86%为女性),症状持续时间<1 个月,2006 年春季至 2008 年秋季期间,因上肢症状就诊芬兰职业健康研究所的患者。我们纳入了所有符合体检诊断标准的在职患者。我们排除了符合预定条件的患者。
采用视觉模拟评分法评估疼痛强度,并将最高三分位(切点 60)进行二分法。
肥胖(高腰围的调整比值比为 2.9,95%置信区间为 1.1 至 7.3)、高密度脂蛋白胆固醇(低值的比值比为 3.9,95%置信区间为 1.4 至 10.1)和甘油三酯(高值的比值比为 2.6,95%置信区间为 1.0 至 6.8)与疼痛强度相关。在研究的四种脂肪因子中,只有内脂素与上肢疼痛相关(水平增加 1SD 的调整比值比为 1.4,95%置信区间为 1.0 至 2.1)。
腹部肥胖和脂质可能对上肢软组织疾病的疼痛强度有影响。它们可能通过促炎的疼痛调节分子途径或通过引起软组织病理和供应动脉功能障碍来加重疼痛。在研究的四种脂肪因子中,只有一种(内脂素)与疼痛强度相关。未来需要进一步研究以更好地了解代谢因素与 UESTD 之间的关系。